174 related articles for article (PubMed ID: 20558616)
21. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
Sasca D; Szybinski J; Schüler A; Shah V; Heidelberger J; Haehnel PS; Dolnik A; Kriege O; Fehr EM; Gebhardt WH; Reid G; Scholl C; Theobald M; Bullinger L; Beli P; Kindler T
Blood; 2019 May; 133(21):2305-2319. PubMed ID: 30814062
[TBL] [Abstract][Full Text] [Related]
22. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
23. PTK7 regulates Id1 expression in CD44-high glioma cells.
Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
[TBL] [Abstract][Full Text] [Related]
24. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.
Leitner M; Poturnayova A; Lamprecht C; Weich S; Snejdarkova M; Karpisova I; Hianik T; Ebner A
Anal Bioanal Chem; 2017 Apr; 409(11):2767-2776. PubMed ID: 28229174
[TBL] [Abstract][Full Text] [Related]
26. Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells.
Golubkov VS; Strongin AY
Cell Commun Signal; 2014 Mar; 12():15. PubMed ID: 24618420
[TBL] [Abstract][Full Text] [Related]
27. Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/β-catenin-dependent cell fate decisions during vertebrate development.
Hayes M; Naito M; Daulat A; Angers S; Ciruna B
Development; 2013 Apr; 140(8):1807-18. PubMed ID: 23533179
[TBL] [Abstract][Full Text] [Related]
28. PTK7: a new biomarker for immunophenotypic characterization of maturing T cells and T cell acute lymphoblastic leukemia.
Jiang G; Zhang M; Yue B; Yang M; Carter C; Al-Quran SZ; Li B; Li Y
Leuk Res; 2012 Nov; 36(11):1347-53. PubMed ID: 22898210
[TBL] [Abstract][Full Text] [Related]
29. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
30. DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.
Mishra SV; Banerjee A; Sarkar D; Thangarathnam V; Bagal B; Hasan SK; Dutt S
J Cell Sci; 2024 Feb; 137(3):. PubMed ID: 38240344
[TBL] [Abstract][Full Text] [Related]
31. PTK7 recruits dsh to regulate neural crest migration.
Shnitsar I; Borchers A
Development; 2008 Dec; 135(24):4015-24. PubMed ID: 19004858
[TBL] [Abstract][Full Text] [Related]
32. Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).
Golubkov VS; Strongin AY
J Biol Chem; 2012 Dec; 287(50):42009-18. PubMed ID: 23095747
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic Value of
LE N; Yang JJ; Liu YC; Zhang XW; Wang H; Wen YN; Jiao YF; Wang LL; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):355-364. PubMed ID: 38660836
[TBL] [Abstract][Full Text] [Related]
34. CD45
Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
[TBL] [Abstract][Full Text] [Related]
35. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
36. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
Prus E; Fibach E
Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
[TBL] [Abstract][Full Text] [Related]
37. Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis.
Shin WS; Na HW; Lee ST
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2251-60. PubMed ID: 25986862
[TBL] [Abstract][Full Text] [Related]
38. Ptk7-Deficient Mice Have Decreased Hematopoietic Stem Cell Pools as a Result of Deregulated Proliferation and Migration.
Lhoumeau AC; Arcangeli ML; De Grandis M; Giordano M; Orsoni JC; Lembo F; Bardin F; Marchetto S; Aurrand-Lions M; Borg JP
J Immunol; 2016 May; 196(10):4367-77. PubMed ID: 27183644
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.
Akiyama H; Umezawa Y; Ishida S; Okada K; Nogami A; Miura O
Cancer Lett; 2019 Jul; 453():84-94. PubMed ID: 30946869
[TBL] [Abstract][Full Text] [Related]
40. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
